eli lilly clinical trials tirzepatide weight loss drug data released Eli Lilly's Zepbound available in

Before starting Melanotan, we should talk to a healthcare provider

PT-141 has shown promise in addressing conditions like erectile dysfunction and hypoactive sexual desire disorder

Add Buccal & Lymphatic Massage to your wellness routine and feel the difference from the inside out.

Source for the systematic evidence on GLP-1 receptor agonists' effects on mesenchymal stem cell populations including those relevant to skin

Standard BMI categories are: Underweight: BMI less than 18.5 kg/m2 Healthy weight: BMI of 18.5 to less than 25 kg/m2 Overweight: BMI of 25 to less than 30 kg/m2 Obesity: BMI of 30 kg/m2 or more Class 1 obesity: 30 to less than 35 kg/m2 Class 2 obesity: 35 to less than 40 kg/m2 Class 3 obesity: 40 kg/m2 or more FDA-approved weight loss drugs are typically prescribed for adults with obesity (BMI of 30 or more) or overweight (BMI of 27 or more) plus a weight-related medical condition

Shima Hadidchi, MD , specializes in helping patients achieve lasting weight loss through the use of Semaglutide GLP-1 injections